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INTRODUCTION:
The overall objective of this proposal was to identify a prostate cancer stem cell population that may be targeted in an effort to eradicate disease that is not effectively managed by localized treatments. To do this, we generated a collection of human prostaspheres, derived from benign and malignant surgical specimens. Studies in other organ systems have indicated that sphere-forming cells are predominately stem and early progenitor cells. Therefore, the sphere assay may be utilized to expand and cultivate the rare prostate epithelial stem cell population. Characterization of prostaspheres could then exploited to provide a wealth of information related to normal prostate development as well as tumor biology. Biomarker identification on putative stem/progenitor cells may lead to novel therapeutic targets. We formulated an approach for studying the stem cell properties of cells comprising prostaspheres, outlined in the specific aims.
BODY:
As described above, several studies in multiple organ systems have shown that cells with stem-like qualities can form spheres. These sphere-forming cells can be induced to differentiate in vitro, or form glands and recapitulate tumors via reconstitution experiments in vivo in a variety of organ systems. The development of prostasphere technology may enable in-depth characterization of stem cells derived from normal and cancerous prostate tissue, with the long-term translational goal of exploiting specific therapeutic targets within this population. As a first step in this developmental project, we proposed the following exploratory aims. Patient Population and Tissue Acquisition: We recruited patients undergoing prostate surgery at UCLA to participate in tissue donation to the UCLA Epithelial Tumor Bank via an approved protocol through the Office for the Protection of Research Subjects (OPRS). Informed consent was obtained from willing subjects. Once the surgical specimen was removed en bloc, it was brought to the surgical pathology grossing room, where a pathologist assisted in obtaining samples of prostate tissue in a sterile manner. An adjacent section from each specimen was paraffin-embedded for histological determination of the presence of normal or cancerous glands. The fresh prostate tissue samples were placed on ice, followed by immediate transport to the laboratory for processing. All surgical specimens were coded for patient anonymity.
Tissue Dissociation and Culture: Prostate tissue was weighed and then minced into small pieces via sharp dissection. Tissue fragments were digested in a 0.25% solution of type I collagenase overnight. After 12 hrs, cells were washed in phosphobuffered saline (PBS), followed by further digestion with trypsin. Dissociated cells were separated from undigested organoids by sequential filtering through 100-and 40-micron mesh. Single cell suspensions were divided and mixed in suspension with 50:50 Matrigel:prostate epithelial cell basal medium (PrEGM, Clonetics), or as a monolayer of prostate epithelial cells on adherent plates. In all of our experiments, cells were counted and assessed for viability after dissociation and prior to plating and/or passaging. Quantitation of prostaspheres derived from each specimen was performed. Aliquots of dissociated cells/spheres were isolated and maintained in liquid nitrogen storage for future analysis.
Development of Human Prostaspheres:
We generated spheres from prostate tissue specimens of 60 patients undergoing cancer surgery. Prostaspheres developed indiscriminately from all tissue types, regardless of Gleason grade, with 1 to 4% of unfractionated cells capable of sphere formation. Variability in the efficiency of prostasphere development was observed among samples but did not appear to be associated with any patient clinical or pathological characteristics. 
Prostaspheres Express Basal Markers:
Materials/Methods/Outcomes (Aim 2):
To assess the self-renewal potential of human prostaspheres, dissociation of the spheres into single cell suspensions were performed followed by re-plating in Matrigel. New spheres were observed in independent experiments with a variety of patient specimens for more than 16 generations. Prostaspheres that were culture for >2 weeks in Matrigel formed branching structures, demonstrating differentiation capability. Please see appendix for manuscript with all figures.
Tissue Regeneration Capability of Prostaspheres:
In addition to in vivo branching structures, subcutaneous injection of prostaspheres combined with Matrigel and rat urogenital sinus mesenchyme (UGSM) into immunocompromised mice resulted in xenograft formation with acinar-like structures resembling partially differentiated prostate glands. These glands demonstrated expression of several prostate markers, including prostate stem cell antigen (PSCA), AR, CK5, CK8, and p63.
KEY RESEARCH ACCOMPLISHMENTS:
Determination of in vitro culture condition for development and expansion of human prostaspheres Demonstration of self-renewal capability of prostapsheres Antigenic profile of sphere-forming cells Demonstration of branching morphagenesis of sphere-forming cells in vitro Demonstration of tissue-regeneration capability of prostaspheres in vivo REPORTABLE OUTCOMES: We have generated a manuscript of our findings that we are in the process of submitting. This manuscript is included in the appendix for a detailed description of all materials, methods, and findings related to prostaspheres.
CONCLUSIONS:
Since initiation of funding, we have accomplished all of the goals outlined in the original statement of work. Additionally, we have generated an extensive collection of human prostaspheres from the spectrum of prostate tissue specimens that are viable in culture and are a continuous source of human material for the study of prostate gland development and tumor initiation in vitro and in vivo. The foundation of work enabled by this grant will enable future funding to continue investigating prostate stem cells via this approach. 
APPENDICES:
